Rituximab in heavily pretreated cutaneous B-cell lymphoma.

作者信息

Zinzani Pier Luigi, Stefoni Vittorio, Alinari Lapo, Vianelli Nicola, Baccarani Michele

出版信息

Leuk Lymphoma. 2003 Sep;44(9):1637-8. doi: 10.3109/10428190309178793.

DOI:10.3109/10428190309178793

PMID:14565673

Abstract

摘要

相似文献

Rituximab in heavily pretreated cutaneous B-cell lymphoma.

Leuk Lymphoma. 2003 Sep;44(9):1637-8. doi: 10.3109/10428190309178793.

Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.

Acta Haematol. 2001;106(3):141-2. doi: 10.1159/000046607.

Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.

Clin Lymphoma Myeloma. 2009 Oct;9(5):381-5. doi: 10.3816/CLM.2009.n.074.

Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.

Leuk Lymphoma. 1999 Nov;35(5-6):641-2. doi: 10.1080/10428199909169633.

Modified chop-chemotherapy plus rituximab for diffuse large b-cell lymphoma complicating ataxia-telangiectasia.

Br J Haematol. 2003 Jan;120(2):369-71. doi: 10.1046/j.1365-2141.2003.04041_4.x.

Lymphomatoid granulomatosis treated with rituximab and chemotherapy.

Clin Adv Hematol Oncol. 2003 Nov;1(11):658-60; discussion 660.

Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study.

Ann Oncol. 2004 Mar;15(3):511-6. doi: 10.1093/annonc/mdh093.

Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.

Arch Dermatol. 2009 Mar;145(3):329-30. doi: 10.1001/archdermatol.2009.23.

Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma.

Leuk Res. 1992;16(4):417-8. doi: 10.1016/0145-2126(92)90146-x.

Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.

Leuk Res. 2002 Mar;26(3):229-34. doi: 10.1016/s0145-2126(01)00114-x.

引用本文的文献

Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.

Front Immunol. 2022 Jan 18;12:838082. doi: 10.3389/fimmu.2021.838082. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验